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Abstract
Background: Previous work suggested that macrophage migration inhibitory factor (MIF) may be
involved in bladder inflammation. Therefore, the location of MIF was determined
immunohistochemically in the bladder, prostate, major pelvic ganglia, sympathetic chain, the L6-S1
dorsal root ganglia (DRG) and the lumbosacral spinal cord of the rat.
Results: In the pelvic organs, MIF immunostaining was prominent in the epithelia. MIF was widely
present in neurons in the MPG and the sympathetic chain. Some of those neurons also co-localized
tyrosine hydroxylase (TH). In the DRGs, some of the neurons that stained for MIF also stained for
Substance P. In the lumbosacral spinal cord, MIF immunostaining was observed in the white mater,
the dorsal horn, the intermediolateral region and in the area around the central canal. Many cells
were intensely stained for MIF and glial fibrillary acidic protein (GFAP) suggesting they were glial
cells. However, some cells in the lumbosacral dorsal horn were MIF positive, GFAP negative cells
suggestive of neurons.
Conclusions: Therefore, MIF, a pro-inflammatory cytokine, is localized to pelvic organs and also
in neurons of the peripheral and central nervous tissues that innervate those organs. Changes in
MIF's expression at the end organ and at peripheral and central nervous system sites suggest that
MIF is involved in pelvic viscera inflammation and may act at several levels to promote inflammatory
changes.
Background
Macrophage migration inhibitory factor (MIF) is a proin-
flammatory cytokine that may play a role in several dis-
ease states, including arthritis, sepsis, Crohn's disease,
allograft rejection, asthma and prostate cancer [1–3].
Although MIF was initially described as released from acti-
vated T-cells [4,5], subsequent investigations have local-
ized MIF in a variety of other cells and tissues (for a recent
review [1]). For example, pre-formed MIF stores can be
found in the epithelia of several organs and may be
released in response to endotoxemia [6]. The role of MIF
in the central nervous system remains to be determined,
yet neurons in the brain synthesize and rapidly release
MIF while glial cells appear to store MIF [7,8], and the
anterior pituitary gland contains MIF that may be released
during endotoxemia [9].
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Recent evidence from our laboratory showed that MIF is
located in the bladder of the rat and also in peripheral
ganglia innervating the bladder and other pelvic viscera.
The urothelium contains a rich store of pre-formed MIF
[10,11]. Moreover, MIF protein and mRNA were also
detected by Western blotting techniques and RT-PCR in
the major pelvic ganglia (MPG) that provides efferent
(parasympathetic and sympathetic) innervation to the
bladder and other pelvic viscera [12,13]. In addition, the
L6-S1 dorsal root ganglia (DRG) that provide afferent
innervation to the bladder [13] and other pelvic viscera
constitutively expressed MIF. Finally, the lumbosacral spi-
nal cord of the rat where afferent and efferent information
is integrated to result in effective pelvic viscera function
[14], was also shown to contain MIF protein and mRNA.
Acute bladder inflammation induced by local (intravesi-
cal) administration of chemical irritants or lipopolysac-
charide altered the levels of this cytokine in the bladder
suggesting that MIF may be implicated in the early stages
of bladder inflammation [10,11]. In addition, there were
changes in the levels of MIF and cyclooxygenase-2 in the
central and peripheral nervous tissues that innervate the
bladder and other pelvic viscera. Therefore, in addition to
the local inflammatory effect, MIF may also be involved in
neurogenically mediated changes at both central and
peripheral nervous system sites following visceral
inflammation.
Our previous studies reported the anatomical localization
for MIF only in the bladder, while the location of MIF in
the peripheral ganglia (MPG; DRG) and in the lumbosac-
ral spinal cord was not determined since the focus was on
the change in MIF amounts in these tissues following
bladder inflammation [10,11]. Therefore, as part of our
ongoing investigations on the role of MIF in pelvic viscera
inflammation, we investigated the location of MIF in two
pelvic organs (bladder and prostate) and in peripheral
ganglia that innervate these viscera using immunohisto-
chemistry. We examined the major pelvic ganglia, where
the parasympathetic and sympathetic neurons that inner-
vate the bladder and the prostate are located. Also, we
investigated the inferior mesenteric ganglia and the lum-
bar sympathetic chain that provide sympathetic innerva-
tion to the bladder and other pelvic viscera [13]. We also
determined the location of MIF in the L6-S1 dorsal root
ganglia that provide afferent innervation to these organs.
Finally, we localized MIF within the lumbosacral spinal
cord since the spinal cord integrates afferent and efferent
information from the pelvic viscera [14].
Results
MIF in the bladder and the prostate
Intense MIF immunoreactivity in the urothelium was
observed in the bladders of both male and female rats,
confirming our previous observations [11]. The staining
was most intense in the basal and intermediate layers of
the urothelium (Fig. 1A,1B). The superficial layer of the
urothelium showed slight MIF immunostaining but also
showed areas that appeared clear of MIF staining (Fig 1B).
In addition, the fibroblasts in the lamina propria, imme-
diately under the urothelium also showed MIF immuno-
reactivity (Fig 1B). Finally, MIF immunoreactivity was
also observed in the smooth muscle in the bladder, con-
firming our previous findings. Some nuclei in smooth
muscle fibers appeared to stain with MIF and weak, dif-
fuse staining was also observed in the cytoplasm of
smooth muscle fiber cells (Fig 1C).
In the prostate, MIF immunostaining was observed in the
acini (Fig 1D,1E,1F) with the majority of the MIF staining
localized to acinar epithelial cells. Occasionally, proximal
acini, following the classification of Lee et al. [15], could
be observed in some sections (Fig 1D,1E). Proximal acini
could be distinguished from peripheral and central acini
by the cuboidal (as opposed to columnar) epithelial cells
and by the presence of surrounding smooth muscle layers.
The MIF staining in the proximal acini was more intense
than in the central acini where the MIF staining was lim-
ited to basal epithelial cells (Fig 1F). No immunofluores-
cence was observed in tissue sections exposed to
preabsorbed antisera or where the primary antiserum had
been omitted (data not shown).
The concentration of MIF in the bladder and the prostate
was also determined using ELISA and expressed as ng of
MIF protein/mg of total protein. In male rats, the bladder
had a mean MIF protein concentration of 200.8 (± 5.75)
ng/mg, whereas in the female bladder the MIF protein
concentration was 67.3 (± 13) ng/mg. This difference was
statistically significant (p < 0.05). The MIF protein con-
centration in the ventral lobe of the prostate was 144.1 (±
28.65) ng/mg.
MIF in the Major Pelvic Ganglia, Inferior Mesenteric 
Ganglia and Sympathetic Chain
MIF staining was observed in cells of the MPG of both
males and female rats. The staining intensity varied with
some cells showing intense staining (Fig 2A) and most
cells showing moderate to weak staining. Some of the
more intensely stained MIF containing cells also stained
for TH (Fig. 2B). Thus, MIF staining was observed in sym-
pathetic and parasympathetic cells of the MPG.
Neurons in the inferior mesenteric ganglia also displayed
MIF immunofluorescence. Cells showing immunofluo-
rescence for both MIF and TH were also observed (Fig
2C,2D). However, the MIF staining in the inferior
mesenteric ganglion appeared less intense overall than in
the MPG. Small intensely fluorescent (SIF) cells, intenselyBMC Neuroscience 2003, 4 http://www.biomedcentral.com/1471-2202/4/17
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MIF immunohistochemistry in the bladder and prostate Figure 1
MIF immunohistochemistry in the bladder and prostate. The bladder showed strong MIF immunostaining in the urothelium (Fig 
1A,1B). The superficial layer of the urothelium had weak MIF immunostaining with some areas devoid of stain (Fig 1B; arrow-
heads), whereas the deeper layers of the urothelium showed intense MIF staining (long arrows). The fibroblasts immediately 
under the urothelium also exhibited MIF staining (arrow with asterisk). The smooth muscle of the bladder also showed MIF 
immunostaining (Fig. 1C) in the cytoplasm of muscle fibers and in nuclei. In the prostate, intense MIF immunostaining was 
observed in the acini (Fig 1D,1E,1F). Epithelial cells in the proximal acini showed strong MIF immunostaining (Fig 1D,1E) and 
the smooth muscle surrounding those acini also showed MIF immunostaining (Fig 1E; long arrows). However, in central and 
peripheral acini, only basal epithelial cells showed MIF immunostaining (Fig 1E, arrowhead; F, long arrows). bv = blood vessel. 
Calibration bar: A,D = 200 µm; B,C,E,F = 100 µm.BMC Neuroscience 2003, 4 http://www.biomedcentral.com/1471-2202/4/17
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MIF immunohistochemistry in the peripheral ganglia of the rat Figure 2
MIF immunohistochemistry in the peripheral ganglia of the rat. Neurons in the MPG showed weak to moderate MIF immunos-
taining (Fig 2A). Some of these neurons also co-contained TH (Fig. 2B). Double arrows illustrate neurons that contained MIF 
and also contained TH, marked in panel 2B with single arrows. However, some of the neurons that were stained with MIF (Sin-
gle arrow) were not TH-positive (* in 2B). Therefore, both sympathetic and parasympathetic neurons in the MPG contained 
MIF. MIF was detected in neurons in the IMG (Fig 2C) and in neurons in the lumbar sympathetic chain (Fig 2E). Arrowheads 
indicate neurons that were identified as containing MIF and TH (Fig 2D,2F) in the IMG and the sympathetic chain. SIF cells in 
the IMG (large arrowhead) also contained MIF and TH (Fig. 2C,2D). Many of the neurons in the L6/S1 DRG stained for MIF. 
Weak to moderate immunostaining was observed in the cytoplasm of the neurons (Fig. 2G). Arrows illustrate some of the 
more intensely stained MIF containing neurons that also contained substance P (Figure 2H) In addition, the satellite cells sur-
rounding the neurons were intensely stained for MIF. One such example is marked with double arrowheads in Fig. 2G, how-
ever, other examples are visible but not marked. Calibration bar = 100 µm.BMC Neuroscience 2003, 4 http://www.biomedcentral.com/1471-2202/4/17
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stained with TH, showed little to moderate MIF staining
in the IMG (Fig. 2C) and MPG. Finally, nearly every cell in
the sympathetic chain showed some degree of MIF immu-
noreactivity. More intensely staining cells could be
located that also stained for TH (Fig. 2E,2F).
MIF in the dorsal root ganglia
MIF immunoreactivity was observed over most of the neu-
rons in the L6/S1 DRG of rats of either sex. Some cells
appeared intensely stained (Fig 2G) and some of these
intensely stained MIF-containing neurons also stained for
substance P (Fig. 2H). Many of the DRG neurons showed
weak MIF immunostaining. The satellite cells surrounding
the DRG neurons, however, were intensely stained for
MIF.
Control sections that were exposed to both the MIF block-
ing peptide and the antiserum or those that did not
receive primary antiserum to MIF, did not show any
immunoreactivity (data not shown). Furthermore, in sec-
tions where one of the antisera (either MIF or TH/SP) had
been omitted, but still processed for double immunofluo-
rescence, only the appropriate immunoreactivity was
observed, indicating that the secondary antibodies were
not cross reacting to produce spurious labeling (data not
shown).
MIF in the lumbosacral spinal cord
In the L6-S1 spinal cord, many cells were immunostained
with MIF antisera. Intensely stained cells were observed
throughout the white matter (Fig 3A). In addition, some
intensely stained and some weakly stained cells were
observed in the dorsal horn (Fig 3B). The dorsal horn also
showed diffuse staining that could not be associated with
particular cells but was limited to the dorsal horn and did
not extent to the intermediate grey matter (Fig 3B).
In the intermediate gray matter, weakly staining MIF pos-
itive cells were located in the region around the central
canal and in the IML region (Fig 3C,3D). The ventral
horns and particularly the motor neurons were devoid of
MIF immunostaining (data not shown).
In order to establish if the MIF stained cells were neurons
or glia, we employed double-immunofluorescence with
MIF and GFAP. All the MIF staining cells in the white mat-
ter also showed GFAP staining (Fig 4A), as would be
expected. In the dorsal horn, although the great majority
of the MIF cells also localized GFAP, indicating they were
glial in origin, some cells also showed only MIF staining
without GFAP suggesting that MIF could also be localized
in neurons (Fig 4B,4C). In the IML region, only double-
labeled cells were observed, suggesting that only glial cells
containing MIF were detected in the IML region (Fig 4D).
Discussion
Results in the present study revealed the location of MIF
protein in the bladder and prostate of the rat and in the
central and peripheral nervous system tissues that inner-
vate these organs.
MIF was localized mainly to epithelia of the bladder and
the prostate. In the bladder, a relatively strong MIF stain-
ing was observed in the basal and intermediate layers of
the urothelium of male and female rats confirming and
extending our recent findings in male rats [10,11]. The
superficial layer of the urothelium, on the other hand,
contained relatively weak staining and areas devoid of
MIF staining were often encountered. A similar pattern of
MIF immunostaining was described for human epidermis
with the basal layer displaying strong MIF staining and
weaker staining in the more superficial layers [16]. MIF
staining was also observed in the acini of the ventral lobe
of the prostate. In the central acini, the labeling was lim-
ited to basal epithelial cells while columnar epithelial
cells appeared devoid of MIF immunofluorescence. Prox-
imal acini, however, showed intense staining in the cuboi-
dal epithelia. These differences in epithelial MIF staining
within the bladder and the prostate suggest a change in
MIF synthesis as epithelia undergo differentiation as has
been reported for the eye lens [17]. Basal cells in the
urothelium undergo proliferation to give rise to the inter-
mediate and superficial layers [18] and MIF expression
was correlated with cell differentiation in the lens [17].
Therefore, it is possible that MIF is involved in cell
differentiation in the urothelium and in other organs, as
suggested by earlier investigations [16,17]. Alternatively,
since the present study did not visualize MIF mRNA using
in situ hybridization, it is possible that cells in the super-
ficial layer of the urothelium synthesize MIF but release it
more quickly than deeper epithelial cells.
In addition to the epithelial staining, we also observed sig-
nificant MIF staining in the bladder smooth muscle cells
with some fibers showing both cytoplasmic and nuclear
staining. Weak MIF staining of the smooth muscle fibers
around proximal acini was also observed. Other investiga-
tors have also reported MIF immunostaining in smooth
muscle [6,19]. Fibroblasts in the lamina propia of the
bladder were also stained for MIF. We observed a differ-
ence in the total bladder MIF protein content between
male and female rats, with male rats having considerably
more MIF protein. We were unable to locate reports of sex
differences in MIF content in the literature. These prelim-
inary findings are interesting but the physiological signif-
icance, if any, remains unclear at this point.
Previously, MIF was described in the epithelia of several
organs of the rat [6]. The present findings provide ana-
tomical evidence of MIF protein in the bladder andBMC Neuroscience 2003, 4 http://www.biomedcentral.com/1471-2202/4/17
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prostate epithelia of the rat and confirm our earlier find-
ings demonstrating MIF expression in the bladder by
immunohistochemistry, Western blotting analysis and
RT-PCR [10,11]. In other organs, the MIF stored in the epi-
thelia was released upon endotoxemia [7]. As such, MIF
may form part of the innate immune response of different
organs to bacterial infection.
The exact role of MIF in the bladder and/or the prostate of
the rat is under investigation. Previously, we had shown
that a chemical cystitis model (intravesical hydrochloric
acid) decreased the overall MIF protein content in the
bladder. This effect was likely due to epithelial denuda-
tion. However, histological evidence showed increased
MIF staining over smooth muscle fiber bundles, perhaps
indicating a role for MIF in the early stages of inflamma-
tion. Furthermore, intravesical LPS (another commonly
used cystitis model in rodents) actually increased total
bladder MIF protein and mRNA content [10]. Therefore, it
is possible that MIF may be involved in the early
responses of the bladder to inflammatory stimuli.
MIF immunohistochemistry in the lumbosacral spinal cord Figure 3
MIF immunohistochemistry in the lumbosacral spinal cord. A) Low power view of a section processed for MIF PAP. Many 
intensely labeled cells are observed in the white mater, the dorsal horn and in the IML region. Diffuse staining was observed in 
the dorsal horn. Moderately stained cells can be seen throughout the intermediate grey and in the area around the central 
canal. B) Higher magnification of the area of the dorsal horn showing labeled profiles. In addition, the dorsal root entry zone 
(marked with an asterisk) also appears labeled with MIF. Diffuse staining over the dorsal horn is marked by the arrows. C) 
Weak to moderately stained cells in the around the central canal. D) MIF stained cells were also observed in the intermedi-
olateral cell region (IML), a region that contains sacral parasympathetic preganglionic neurons and interneurons. Calibration 
bar, A = 400 um; B-D = 100 um.BMC Neuroscience 2003, 4 http://www.biomedcentral.com/1471-2202/4/17
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Interestingly, the MIF protein content in the prostate actu-
ally decreased after intravesical LPS (unpublished
observations). These findings, although preliminary, sug-
gest to us that MIF may be released from prostate epithelia
because of inflammatory events in other pelvic viscera (in
this case, the bladder) and this release may be mediated
by neurogenic reflexes. If this is indeed the case, then MIF
may play a role in neurogenic inflammation and in
visceral referred pain. In humans, MIF protein has been
localized in the prostate of cancer patients [2]. In fact, MIF
may serve as a prognostic marker for prostate cancer since
serum levels correlate with disease progression [3]. There-
fore, MIF may represent an important target for therapeu-
tic intervention in bladder and prostate inflammation and
cancer.
The anatomical location of MIF mRNA and protein has
been described for the adult rat brain [7,8,20]. However,
the spinal cord and peripheral nervous systems have
received less attention [21,22]. In addition to the bladder
and the prostate, MIF appeared to be ubiquitous in neu-
rons of the peripheral ganglia of the rat.
Double immunofluorescence for MIF and GFAP in the lumbosacral spinal cord Figure 4
Double immunofluorescence for MIF and GFAP in the lumbosacral spinal cord. Each panel is a composite of two different pho-
tographs, arranged to overlap each other using Adobe Photoshop. A) In the dorsal funiculi, GFAP immunostaining (red) was 
very prominent. MIF immunostained cells (green) were seen associated with GFAP fibers. Arrow points to midline. In the dor-
sal horn (B & C), many of the MIF immunostained cells (green) were associated with GFAP immunofluorescence (red). How-
ever, some cells appeared to contain only MIF immunostaining (arrow). D. Several MIF immunostained cells are visible in the 
IML region. All of them also reveal GFAP staining. Calibration bar = 100 µm.BMC Neuroscience 2003, 4 http://www.biomedcentral.com/1471-2202/4/17
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Weak to moderate MIF immunostaining was observed in
the neurons of the MPG. The major pelvic ganglia contain
cholinergic and sympathetic neurons that innervate the
bladder, prostate, colon and other pelvic viscera [12]. MIF
immunostaining was localized in both parasympathetic
(TH negative) and sympathetic (TH positive) cells in the
MPG. In addition, the SIF (also TH positive) cells also
contained MIF. These findings provide anatomical locali-
zation for our previous report of constitutive expression of
MIF in the MPG previously [10,11]. Finally, sympathetic
neurons (TH positive) in the inferior mesenteric ganglia
and in the lumbar sympathetic chain also contained MIF.
The lumbar sympathetic chain contains a large proportion
of the sympathetic post-ganglionic neurons that innervate
the bladder while the inferior mesenteric ganglion pro-
vides a much smaller contribution [12]. Although not
directly tested in the present experiment, it is possible that
some of the post-ganglionic neurons that also stained
with MIF innervate the bladder and/or other pelvic
viscera.
We also observed many L6/S1 DRG neurons that con-
tained MIF, as well as intensely stained satellite cells.
Some DRG neurons that were immunostained for MIF
also co-contained the neurotransmitter substance P. Our
findings of MIF in DRG neurons confirm earlier observa-
tions in the embryonic mouse [19]. However, our find-
ings of MIF protein in afferent neurons in the DRG that
also contain substance P represent a novel finding in the
adult rat.
Finally, we observed substantial MIF immunostaining in
the lumbosacral spinal cord of the rat. Glial cells (GFAP
positive) in the white matter and in the gray matter were
intensely immunostained for MIF. Earlier investigations
also reported MIF immunostaining in the white matter of
the spinal cord [21]. However, we also observed cells in
the dorsal horn that stained for MIF but not for GFAP, sug-
gesting they were neuronal rather than glial cells. In the
brain, MIF immunohistochemistry is found strongly in
glial cells with neurons displaying weak (or no) staining
[7]. Therefore, neurons in the brain appear to synthesize
MIF and quickly release it so that nearby glial cells accu-
mulate MIF protein, without synthesizing it. It is possible
that such a mechanism is at work at the level of the spinal
cord.
In addition to cellular labeling with MIF, we also observed
terminal-like labeling over the dorsal horn of the lum-
bosacral spinal cord. This labeling was seen as a band of
MIF immunostaining that was darker in the superficial
layers of the dorsal horn than in the deeper intermediate
gray matter. This pattern of labeling is suggestive of the
terminal fields of afferent neurotransmitters and corrobo-
rates previous reports of MIF terminal labeling in the
brain [7]. However, the staining was diffuse and individ-
ual nerve fibers (such as is the case with afferent neuro-
transmitter immunohistochemistry, for example,
substance P) were not identified. Therefore, more work
needs to be done to document whether the MIF staining
over the dorsal horn represents afferent terminal labeling
or diffuse, glial labeling.
MIF is a pro-inflammatory cytokine that may play a cru-
cial role in initiating or maintaining several inflammatory
conditions [1]. In experimental models, treatment with
antibodies to MIF, reversed or prevented colitis and gastric
ulcer formation [23,24]. MIF is upregulated in neurons in
the brain and released into the CSF following intracister-
nal LPS or spinal cord injury [7,21]. In addition, MIF is
upregulated in the brain after reperfusion subsequent to
ischemia [25]. Therefore, MIF is likely involved in the
brain's response infectious agents or trauma.
Conclusions
Results from the present study establish that MIF protein
is located in epithelia and smooth muscle in two pelvic
organs, the bladder and the prostate. Furthermore, post-
ganglionic (parasympathetic and sympathetic) and affer-
ent neurons also contain MIF protein. Finally, astrocytes
and neurons in the lumbosacral spinal cord contain MIF.
The role of MIF in the integration of pelvic viscera func-
tion is still under investigation. We have recently showed
MIF upregulation in the bladder, in the L6/S1 DRG and in
the lumbosacral cord after induction of acute bladder
inflammation using two different models [10,11]. The
upregulation of MIF in central and peripheral nervous tis-
sues following localized (i.e. bladder) inflammation
raises the interesting possibility that MIF may contribute
to central and peripheral neurogenic events mediating
inflammation. Although cytokines are traditionally asso-
ciated with peripheral immune reactions as part of the
innate response, evidence is accumulating that they may
also be involved in normal brain function and may medi-
ate pathological responses such as hyperalgesia [26,27].
In fact, the abundance of MIF in glia of the spinal cord is
particularly interesting since glial cells have been sug-
gested as involved in hyperalgesia through the release of
cytokines and other substances [28]. Given the presence
of MIF in the pelvic organs (bladder, prostate) and the
central and peripheral nervous system tissues that inner-
vate these organs, as well as the fact that bladder
inflammation appears to upregulate MIF in these areas, it
is possible that MIF represents a therapeutic target in
reducing or preventing pelvic viscera inflammation.
Methods
All experiments were approved by the institutional Ani-
mal Studies Committee and conformed to the NIH guide-
lines for the conduct of experiments on animal subjects.BMC Neuroscience 2003, 4 http://www.biomedcentral.com/1471-2202/4/17
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Perfusion and tissue collection
Six (n = 6) adult Sprague-Dawley (Harlan, IN) rats were
used in this study. Four male (weight = 270–320 g) and
two female (weight = 270–280 g) rats were deeply anaes-
thetized with sodium pentobarbital (80 mg/kg; i.p.) and
perfused transcardially with cold (4°C) Krebs followed by
4% paraformaldehyde in 0.1 M phosphate buffer. The fol-
lowing tissues were removed and placed in fixative at least
overnight: bladder, ventral lobes of the prostate (in the
males), both MPG, the inferior mesenteric ganglia (IMG),
the sympathetic chain (L3-L5), the L6-S1 DRG and the L6-
S1 spinal cord. In two of the males and the two female
rats, the bladders and the ventral lobes of the prostate (in
case of the males) were dissected prior to perfusion. The
bladder was divided in half longitudinally, containing
both dome and base. One half of the bladder and a piece
of the ventral lobes of the prostate were then placed in fix-
ative overnight. The MIF protein concentration of the
remaining bladder and prostate was determined using an
ELISA procedure (see below).
Immunohistochemical procedures
Cryostat sections (10 um) of the bladder (transverse sec-
tions through the dome and the base), prostate and all the
ganglia were thaw-mounted onto gelatin coated slides.
Free-floating cryostat sections (20 um) of the L6-S1 spinal
cord were collected in phosphate buffer. MIF immunohis-
tochemistry, either singly or in combination with other
antigens was carried out in all the tissues according to the
following protocols.
A) Single immunofluorescence
Sections were incubated with 3% normal serum (in 0.01
M phosphate buffer-saline, 0.1 % Triton X-100; 30 min)
followed by incubation with MIF antibody (rabbit poly-
clonal, 1:200; Torrey Pines; Houston, TX) overnight. The
antibody was visualized using an FITC-labeled secondary
antibody (donkey anti-rabbit, 1:50; Jackson; West Grove,
PA). The slides were cover slipped with fade-retardant
media and examined using a Nikon microscope. Photo-
graphs were obtained using a microscope mounted digital
camera (Pixera; Los Gatos, CA) attached to the
microscope.
B) Double immunofluorescence
Sections from the MPG, the IMG and the sympathetic
chain were processed for double-immunofluorescence in
order to visualize both MIF and tyrosine hydroxylase, as
follows: Sections were exposed to 3% normal serum (in
0.01 M phosphate buffer-saline, 0.1 % Tx-100; 30 min)
followed by incubation with anti-MIF (1:200) and anti-
tyrosine hydroxylase (sheep polyclonal antibody; 1:1000;
Pel-Freez; Rogers, AR) overnight at 4°C. The antibodies
were visualized using donkey anti rabbit and donkey anti-
sheep secondary antibodies (Jackson; 1:50), labeled with
FITC and RITC, respectively.
Sections from the DRG were processed for the visualiza-
tion of MIF and substance P as follows: sections were
exposed to anti-MIF (1:200) and anti-substance P (guinea
pig polyclonal; 1:1000; Chemicon; Tamecula, CA) over-
night at 4°C. The antibodies were visualized using donkey
anti rabbit and donkey anti-sheep secondary antibodies
(Jackson; 1:50), labeled with FITC and RITC, respectively.
Some spinal cord sections were also processed for MIF and
GFAP double-immunofluorescence as follows: Sections
were incubated with anti-MIF (1:200) and anti-GFAP
(mouse monoclonal; 1:1000; Chemicon). The antibodies
were visualized using donkey anti rabbit and donkey anti-
sheep secondary antibodies (Jackson), labeled with FITC
and RITC, respectively.
C) Single PAP immunohistochemistry
Free-floating sections from the spinal cord were processed
for MIF using a standard peroxidase-anti-peroxidase tech-
nique. Sections were exposed to 3% H2O2  to reduce
endogenous peroxidase. The sections were then incubated
with 3% normal serum (in 0.01 M phosphate buffer-
saline, 0.1 % Tx-100; 30 min) followed by incubation
with anti-MIF antibody (1:1600) overnight at 4°C and
visualized as described previously [11]. Briefly, the sec-
tions were exposed to a goat anti-rabbit antiserum (Jack-
son; 1:50 in PBS) for 1 hour, followed by exposure to
goat-PAP (Jackson; 1:100 in PBS). The sections were
reacted with diaminobenzidine intensified with nickel
ammonium sulfate. The slides were dehydrated, cleared in
xylene and coverslipped with Permount.
Control experiments aimed to demonstrate the specificity
of the staining with the MIF antibody and to rule out
cross-reactivity of secondary antisera included: 1) preab-
sorption controls: incubation of the MIF antibody with
the peptide used to produce the antibody; 2) omission of
the primary antibody; 3) omission of either one of the pri-
mary antisera used for double-immunofluorescence.
ELISA procedures
Half of the bladders (containing both dome and base) of
two male and two female rats, and the portions of the ven-
tral lobes of the prostates of two male rats were assayed for
MIF protein. Briefly, tissues were homogenized in CHAPS
buffer 10 mM (3-[3-Cholamidropropyl) dimehthylam-
monio]-1-propane-sulfonate, 2 mM EDTA, 4 mM iodoac-
etate in phosphate buffered saline (pH 7.2) with protease
inhibitor cocktail (Invitrogen; Carlsbad, CA) and cleared
tissue lysate prepared by centrifugation at 10,000 g for 15
minutes. MIF concentrations within cell lysates were
determined using a rat MIF ELISA kit (Chemicon). DataPublish with BioMed Central    and   every 
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are presented as Mean (± S.E.M.) MIF concentration per
mg of total protein of duplicate ELISA determinations for
each tissue and from each experimental animal. The
ELISA results were compared using a Student's t-test and a
significant difference was defined as p < 0.05.
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